The family that owns Spanish drugmaker Grifols and private equity firm Brookfield are considering whether to take the company private in a deal that could be worth around €5.5 billion (almost $6 ...
Grifols (NASDAQ:GRFS) announced Monday that Raimon Grifols and Víctor Grifols Deu, members of its founding family, have decided to step down from their executive roles, and Nacho Abia, a former ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback